• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vaccine for prophylaxis and immunotherapy, Brazil.

作者信息

Genaro O, de Toledo V P, da Costa C A, Hermeto M V, Afonso L C, Mayrink W

机构信息

Departmento de Parasitologia, Universidade Federal de Minas Gerais, Brazil.

出版信息

Clin Dermatol. 1996 Sep-Oct;14(5):503-12. doi: 10.1016/0738-081x(96)00040-5.

DOI:10.1016/0738-081x(96)00040-5
PMID:8889328
Abstract
摘要

相似文献

1
Vaccine for prophylaxis and immunotherapy, Brazil.用于预防和免疫治疗的疫苗，巴西。
Clin Dermatol. 1996 Sep-Oct;14(5):503-12. doi: 10.1016/0738-081x(96)00040-5.
2
Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela.利什曼病：委内瑞拉的免疫学、临床方面及疫苗
Clin Dermatol. 1996 Sep-Oct;14(5):479-87. doi: 10.1016/0738-081x(96)00042-9.
3
Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil.免疫疗法治疗美洲皮肤利什曼病：巴西的初步研究。
Parassitologia. 1992 Dec;34(1-3):159-65.
4
Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report.用含有巴氏消毒利什曼原虫前鞭毛体和卡介苗的疫苗治疗委内瑞拉严重黏膜皮肤型或弥漫性皮肤利什曼病早期病变患者：初步报告。
Mem Inst Oswaldo Cruz. 2004 Feb;99(1):57-62. doi: 10.1590/s0074-02762004000100010. Epub 2004 Mar 31.
5
Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.在感染巴西利什曼原虫（维安尼亚种）的小鼠模型中对四种利什曼原虫疫苗候选物进行测试，巴西利什曼原虫（维安尼亚种）是新世界皮肤利什曼病的主要病原体。
Clin Vaccine Immunol. 2007 Sep;14(9):1173-81. doi: 10.1128/CVI.00060-07. Epub 2007 Jul 11.
6
Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.在新世界皮肤利什曼病的小鼠模型中，利什曼原虫无鞭毛体抗原与脂多糖类似物ONO - 4007联合疫苗接种对亚马逊利什曼原虫感染进行免疫预防和免疫治疗的效果。
Vaccine. 2006 Jul 7;24(27-28):5645-52. doi: 10.1016/j.vaccine.2006.03.023. Epub 2006 Mar 29.
7
Vaccination of C57BL/10 mice against cutaneous Leishmaniasis using killed promastigotes of different strains and species of Leishmania.使用不同菌株和物种的利什曼原虫灭活前鞭毛体对C57BL/10小鼠进行皮肤利什曼病疫苗接种。
Rev Soc Bras Med Trop. 2002 Mar-Apr;35(2):125-32. doi: 10.1590/s0037-86822002000200001.
8
The challenges on developing vaccine against visceral leishmaniasis.开发抗内脏利什曼病疫苗面临的挑战。
Rev Soc Bras Med Trop. 2016 Jul-Aug;49(4):395-7. doi: 10.1590/0037-8682-0343-2016.
9
The potential of live attenuated vaccines against Cutaneous Leishmaniasis.减毒活疫苗防治皮肤利什曼病的潜力。
Exp Parasitol. 2020 Mar;210:107849. doi: 10.1016/j.exppara.2020.107849. Epub 2020 Feb 3.
10
Leishmaniasis vaccine.利什曼病疫苗
Drugs R D. 1999 Sep;2(3):208-10. doi: 10.2165/00126839-199902030-00014.

引用本文的文献

1
Advances in Vaccines: Current Development and Future Prospects.疫苗进展：当前发展与未来前景
Pathogens. 2024 Sep 20;13(9):812. doi: 10.3390/pathogens13090812.
2
Efficacy of Four spp. Extracts in an Animal Model of Cutaneous Leishmaniasis.四种植物提取物在皮肤利什曼病动物模型中的疗效
Medicines (Basel). 2018 Jun 5;5(2):49. doi: 10.3390/medicines5020049.
3
Leishmaniasis in humans: drug or vaccine therapy?人类利什曼病：药物治疗还是疫苗治疗？
Drug Des Devel Ther. 2017 Dec 22;12:25-40. doi: 10.2147/DDDT.S146521. eCollection 2018.
4
Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.利用与疫苗相关的TLR激动剂佐剂，从感染婴儿利什曼原虫的犬中恢复抗原特异性T细胞反应。
Vaccine. 2016 Oct 17;34(44):5225-5234. doi: 10.1016/j.vaccine.2016.09.016. Epub 2016 Sep 21.
5
Parasites and immunotherapy: with or against?寄生虫与免疫疗法：是助力还是对抗？
J Parasit Dis. 2016 Jun;40(2):217-26. doi: 10.1007/s12639-014-0533-4. Epub 2014 Aug 31.
6
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.用于预防内脏利什曼病的候选疫苗抗原的策略性评估。
Vaccine. 2016 May 27;34(25):2779-86. doi: 10.1016/j.vaccine.2016.04.067. Epub 2016 May 1.
7
Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.内脏利什曼病的免疫治疗和免疫化学治疗：这种被忽视疾病的有前途的治疗方法。
Front Immunol. 2014 Jun 13;5:272. doi: 10.3389/fimmu.2014.00272. eCollection 2014.
8
Development of Leishmania vaccines: predicting the future from past and present experience.利什曼原虫疫苗的研发：从过去和现在的经验预测未来
J Biomed Res. 2013 Mar;27(2):85-102. doi: 10.7555/JBR.27.20120064. Epub 2012 Sep 30.
9
Vaccine Development Against Leishmania donovani.抗杜氏利什曼原虫疫苗的研制。
Front Immunol. 2012 May 15;3:99. doi: 10.3389/fimmu.2012.00099. eCollection 2012.
10
Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates.鉴定内脏利什曼病患者尿液中的恰加斯利什曼原虫蛋白：一种有前途的疫苗候选抗原发现方法。
Parasite Immunol. 2012 Jul;34(7):360-71. doi: 10.1111/j.1365-3024.2012.01365.x.